The forecast for Government Budget Appropriations or Outlays for R&D in Health in France indicates a steady increase from 2024 to 2028, with values rising from $17.95 billion in 2024 to $20.14 billion in 2028 in Billion US Dollars PPP. In 2023, the budget stood at $17.96 billion, reflecting a base point for analysis. The year-on-year growth shows a consistent increase of approximately 3% annually over the forecasted years, indicating a strong commitment from the French government towards health R&D. This upward trend suggests a Compound Annual Growth Rate (CAGR) of about 3% over the five-year period from 2024 to 2028.
Future trends to watch for include the impact of emerging health challenges and technological advancements, which may influence budgetary allocations. Additionally, shifts in economic conditions or governmental policy changes could also affect R&D funding in health. Increased collaboration between international bodies and private sectors may also play a significant role in shaping the landscape of health R&D funding.
